Webcast Accessible via Sarepta Therapeutics Website
CAMBRIDGE, Mass. -- (Business Wire)
Sarepta Therapeutics (NASDAQ: SRPT), a developer of innovative RNA-based
therapeutics, announced today that management will present a company
overview at the Canaccord 34th Annual Growth Conference in
Boston, MA on Wednesday, August 13, 2014, at 4:30 pm, ET. Chris
Garabedian, Sarepta’s president and chief executive officer, will be the
presenter.
This presentation will be webcast live on the investor relations section
of the Sarepta Therapeutics website at www.sarepta.com
and will be archived under the events and presentations section
following the presentation for 90 days.
About Sarepta Therapeutics
Sarepta Therapeutics is focused on developing first-in-class RNA-based
therapeutics to improve and save the lives of people affected by serious
and life-threatening rare and infectious diseases. The Company's diverse
pipeline includes its lead program eteplirsen, for Duchenne muscular
dystrophy, as well as potential treatments for some of the world's most
lethal infectious diseases. Sarepta aims to build a leading, independent
biotech company dedicated to translating its RNA-based science into
transformational therapeutics for patients who face significant unmet
medical needs. For more information, please visit us at www.sarepta.com.
Contacts:
Sarepta Investor Contact:
Stephanie Ascher, 212-362-1200
stephanie@sternir.com
or
Sarepta
Media Contact:
Lauren Magnetti, 917-334-0353
lmagnetti@6degreespr.com
Source: Sarepta Therapeutics
© 2024 Canjex Publishing Ltd. All rights reserved.